The Discounted Cash Flow (DCF) valuation of Panaxia Labs Israel Ltd (PNAX.TA) is (3,859,776.75) ILS. With the latest stock price at 4,738.00 ILS, the upside of Panaxia Labs Israel Ltd based on DCF is -81564.3%.
Based on the latest price of 4,738.00 ILS and our DCF valuation, Panaxia Labs Israel Ltd (PNAX.TA) is a sell. selling PNAX.TA stocks now will result in a potential gain of 81564.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.8% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (9,254,632.22) - (2,468,099.00) | (3,859,776.75) |
| Upside | -195427.8% - -52191.6% | -81564.3% |